Companies · Listed company · 🇮🇳

Dr. Lal Path Labs Ltd.

LALPATHLAB · NSE · ₹1,971 a share (close of 05 Oct 2026)

Available company data, source links and archived checks for Dr. Lal Path Labs Ltd.. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.

Revenue rose 19.1%; Net profit was ₹170.50 crore.

Quarter ended 2026-06-30 · consolidated · Company filing

Recorded quarterly figures

Quarter	Revenue / income	YoY	Profit	YoY	Net margin	Source
Jun 2026	Revenue: ₹798 cr	+19.1%	Net profit: ₹170 cr	+27.2%	21.4%	Company filing source
Mar 2026	Revenue: ₹703 cr	+16.6%	Net profit: ₹132 cr	-15.0%	18.8%	Company filing source
Dec 2025	Revenue: ₹660 cr	—	Net profit: ₹91 cr	—	13.9%	Company filing source
Sep 2025	Revenue: ₹731 cr	—	Net profit: ₹152 cr	—	20.8%	Company filing source
Jun 2025	Revenue: ₹670 cr	+11.3%	Net profit: ₹134 cr	+24.3%	20.0%	Company filing source
Mar 2025	Revenue: ₹603 cr	—	Net profit: ₹156 cr	—	25.8%	Company filing source

YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.

Who holds it — from the filings

Arvind Lal 30.1%Vandana Lal 19.2%HDFC MUTUAL FUND - HDFC RETIREMENT SAVINGS FUND - EQUITY PLAN 3.9%UTI-MID CAP FUND 2.6%NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND 2.6%register as filed 2026-06-30

Filing timeline — what the company told the exchange

Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates - Update on acquisition-SHL… 26 Sep 2026 · document
Dr. Lal Path Labs Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015… 25 Sep 2026 · document
General Updates. Dr. Lal Path Labs Ltd. has informed the Exchange about acquisition of 70% stake in SN Genelab Private Limited ( S N Gene ) from its existing Sh… 24 Sep 2026 · document
Dr. Lal Path Labs Ltd. has informed the Exchange regarding Outcome of Board Meeting held on September 24, 2026.… 24 Sep 2026 · document
Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication… 04 Sep 2026 · document
Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates… 27 Aug 2026 · document
General Updates. Incorporation of a Step-Down Subsidiary Company… 19 Aug 2026 · document

Follow this company without reading every document yourself.

Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.

Start free — first week on us →

India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment advice · cancel any time

Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances